MEDICO-DENTAL CASE RECORDS: FIFTH REPORT
- Meningococcal disease: R.Ph.s play key role. Breu, Joe // Drug Topics;5/20/96, Vol. 140 Issue 10, p35
Reports on the American Academy of Pediatrics' (AAP) issuance of treatment recommendations for meningococcal disease. Pharmacists' role in the treatment process.
- Streptococcus pneumoniae meningitis in an adult with normal cerebrospinal fluid. Montassier, Emmanuel; Trewick, David; Batard, Eric; Potel, Gilles // CMAJ: Canadian Medical Association Journal;10/4/2011, Vol. 183 Issue 14, p1618
The article presents a case study of a 60-year-old woman who was taken to the emergency department due to fever and headache. The patient has history of an appendectomy and hysterectomy. It adds that the initial blood culture has confirmed that the patient was positive for Streptococcus...
- Meningitis becomes resistant to drugs. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);10/03/98, Vol. 317 Issue 7163, p902
States that the strains of type B Neisseria meningitidis, is becoming resistant to the drug which is commonly used to treat the disease. Details on the research carried out by scientists at the Pasteur Institute in Paris, France; What N meningitidis is susceptible to; Comments from Dr. Mary...
- Meningococcal septicemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Bjorvatn, Bjarne; Bjertnaes, Lars; Fadnes, Hans Olav; Flaegstad, Trond; Gutteberg, Tore Jarl; Kristiansen, Bjorn-Erik; Pape, Jan; Rekvig, Ole Petter; Osterud, Bjarne; Aanderud, Leif // British Medical Journal (Clinical Research Edition);2/11/1984, Vol. 288 Issue 6415, p439
Examines the use of plasmapheresis, leucapheresis and blood exchange in the treatment of meningococcal septicaemia in Norway. Activation of blood cells by endotoxin; Consideration of the activation as the factor for the pathophysiological changes; Tolerance of the disease on the combined...
- Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action. Jarvis, Joseph N.; Lawn, Stephen D.; Wood, Robin; Harrison, Thomas S. // Clinical Infectious Diseases;12/15/2010, Vol. 51 Issue 12, p1463
A letter to the editor is presented in response to the article regarding the effectiveness of serum cryptococcal antigen (CRAG) screening in patients with cryptococcal meningitis.
- Pneumococcal meningitis and otitis media. Corbeel, L. // European Journal of Pediatrics;May2006, Vol. 165 Issue 5, p283
Presents information on a case study regarding pneumococcal meningitis and otitis media in 159 paediatric patients observed during a 4-year period. Clinical conditions of the patients; Percentage of patients resistant to strains of pneumococci; Factors to consider in treating patients with...
- Meningite Bacteriana Aguda como DoenÃ§a Ocupacional. SEIXAS, Diana; LEBRE, Ana; CRESPO, Pedro; FERREIRA, Eugénia; SERRA, José Eduardo; SARAIVA DA CUNHA, José Gabriel // Acta Medica Portuguesa;jul/ago2014, Vol. 27 Issue 4, p519
Streptococcus suis is a zoonotic pathogen with worldwide distribution, responsible for more than 700 human cases globally reported. This infection affects mostly men, exposed to pig or pork, which leads to its usual classification as an occupational disease. We report a case of acute bacterial...
- Characteristics of invasive pneumococcal disease in hospitalized children in Austria. Paulke-Korinek, Maria; Kollaritsch, Herwig; Kundi, Michael; Schmidle-Loss, Birgit; Zwazl, Ines; Laaber, Brigitte; Lakovits, Karin; Vecsei, Andreas; Wiedermann, Ursula; Burgmann, Heinz // European Journal of Pediatrics;Apr2014, Vol. 173 Issue 4, p469
In a prospective surveillance study covering all pediatric wards in Austria, 308 cases of invasive pneumococcal disease (IPD) were reported in hospitalized children <5 years of age between 2002 and 2012. Incidence was 7.1 per 100,000 per year for IPD with a case fatality rate of 3 %, and 1.9 per...
- MenHibrix Vaccine Approved. // Monthly Prescribing Reference;Jul2012, Vol. 28 Issue 7, pA6
The article informs about the approval of MenHibrix from GlaxoSmithKline for the treatment of those invasive diseases that are caused by Neisseria meningitidis sero groups C and Y and Haemophilus influenzae type b in children.